GLRA3 and irritable bowel syndrome: Here, we describe a remarkable overlap of the fragment hit set of the H4R and the 5-HT3AR. This ligand-gated ion channel is a drug target for the treatment of irritable bowel syndrome (IBS) and chemotherapy-induced nausea and vomiting (CINV).11